$1.1 B

AMPH Mkt cap, 13-Feb-2019

$75.5 M

Amphastar Pharmaceuticals Revenue Q3, 2018
Amphastar Pharmaceuticals Gross profit (Q3, 2018)29.3 M
Amphastar Pharmaceuticals Gross profit margin (Q3, 2018), %38.7%
Amphastar Pharmaceuticals Net income (Q3, 2018)1.6 M
Amphastar Pharmaceuticals EBIT (Q3, 2018)2.6 M
Amphastar Pharmaceuticals Cash, 30-Sep-201868.7 M

Amphastar Pharmaceuticals Revenue

Amphastar Pharmaceuticals revenue was $240.18 m in FY, 2017

Embed Graph

Amphastar Pharmaceuticals Revenue Breakdown

Embed Graph

Amphastar Pharmaceuticals revenue breakdown by business segment: 5.9% from Active Pharmaceutical Ingredients and 94.1% from Finished pharmaceutical products

Amphastar Pharmaceuticals Income Statement

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017

Revenue

210.5m251.5m255.2m240.2m

Revenue growth, %

20%1%

Cost of goods sold

159.2m174.2m151.0m149.4m

Gross profit

51.3m77.3m104.2m90.8m

Gross profit Margin, %

24%31%41%38%

Sales and marketing expense

5.6m

R&D expense

28.4m37.1m41.2m43.4m

General and administrative expense

34.8m41.5m41.8m44.5m

Operating expense total

68.8m84.2m88.5m91.7m

EBIT

(18.0m)(6.9m)15.7m(895.0k)

EBIT margin, %

(9%)(3%)6%0%

Interest expense

609.0k987.0k1.0m826.0k

Interest income

243.0k315.0k270.0k425.0k

Pre tax profit

(18.1m)(10.4m)14.9m1.6m

Income tax expense

(7.4m)(7.6m)4.4m(2.9m)

Net Income

(10.7m)(2.8m)10.5m4.5m

Quarterly

USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Revenue

49.0m59.7m56.9m53.9m63.9m59.4m68.0m64.2m56.7m65.2m57.9m58.4m71.0m75.5m

Cost of goods sold

34.0m47.9m43.6m40.5m46.3m34.5m36.3m36.6m33.8m38.4m37.3m41.3m44.9m46.3m

Gross profit

15.0m11.8m13.3m13.3m17.6m24.9m31.7m27.6m22.8m26.7m20.6m17.1m26.2m29.3m

Gross profit Margin, %

31%20%23%25%28%42%47%43%40%41%36%29%37%39%

R&D expense

6.0m8.6m6.6m10.7m11.1m8.4m10.5m9.7m11.3m10.7m10.0m14.3m15.5m11.3m

General and administrative expense

8.6m9.6m12.5m11.3m9.0m10.9m9.5m10.8m11.3m12.2m11.7m11.0m11.7m13.4m

Operating expense total

16.2m19.6m20.5m23.6m21.3m20.8m21.4m21.8m21.4m24.6m23.5m27.0m29.0m26.7m

EBIT

(1.2m)(7.8m)(7.3m)(10.3m)(3.7m)4.1m10.3m5.8m1.4m2.2m(2.8m)(9.9m)(2.9m)2.6m

EBIT margin, %

(2%)(13%)(13%)(19%)(6%)7%15%9%2%3%(5%)(17%)(4%)3%

Interest expense

476.0k504.0k341.0k210.0k232.0k384.0k305.0k281.0k191.0k237.0k264.0k18.0k100.0k124.0k

Interest income

32.0k94.0k92.0k65.0k83.0k74.0k50.0k63.0k91.0k87.0k124.0k124.0k106.0k105.0k

Pre tax profit

(1.9m)(8.0m)(6.2m)(10.2m)(4.3m)3.8m9.8m6.0m1.5m3.2m(2.0m)(9.0m)(4.1m)2.6m

Income tax expense

(696.0k)(2.6m)(5.5m)(3.6m)(1.3m)1.3m2.9m2.1m611.0k1.2m(2.2m)(1.8m)(1.3m)958.0k

Net Income

(1.2m)(5.4m)(665.0k)(6.6m)(3.0m)2.5m6.9m3.9m893.0k2.0m175.0k(7.2m)(2.8m)1.6m

Amphastar Pharmaceuticals Balance Sheet

Annual

usdY, 2012Y, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

50.2m53.6m67.8m66.1m72.4m65.6m

Accounts Receivable

22.9m33.2m26.8m36.0m

Inventories

118.4m63.6m

Current Assets

198.0m175.9m184.1m187.8m

PP&E

138.3m142.2m152.9m185.3m

Goodwill

42.6m39.9m50.3m45.1m

Total Assets

389.4m390.1m427.7m454.7m

Accounts Payable

10.2m13.9m16.2m57.6m

Current Liabilities

62.6m60.0m60.6m67.2m

Total Liabilities

98.5m117.3m

Additional Paid-in Capital

220.7m247.8m283.1m313.9m

Retained Earnings

63.1m60.3m70.9m76.2m

Total Equity

295.5m329.3m337.3m

Financial Leverage

1.3 x1.3 x1.3 x

Amphastar Pharmaceuticals Cash Flow

Annual

usdFY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(10.7m)(2.8m)10.5m4.5m

Depreciation and Amortization

12.0m12.6m

Accounts Receivable

1.2m6.4m(8.1m)

Inventories

9.1m(9.7m)18.7m

Accounts Payable

7.0m6.7m

Cash From Operating Activities

14.2m(1.8m)38.6m39.2m

Purchases of PP&E

(18.7m)

Cash From Investing Activities

(39.8m)(39.5m)(38.8m)

Long-term Borrowings

(8.2m)(14.7m)(9.7m)

Cash From Financing Activities

32.1m7.1m(7.7m)

Interest Paid

2.6m

Income Taxes Paid

436.0k3.4m4.9m

Amphastar Pharmaceuticals Ratios

USDY, 2018

Financial Leverage

1.4 x
Report incorrect company information

Amphastar Pharmaceuticals Operating Metrics

FY, 2016

Facilities

5

Products

19
Report incorrect company information

Amphastar Pharmaceuticals Employee Rating

2.545 votes
Culture & Values
1.9
Work/Life Balance
2.3
Senior Management
1.9
Salary & Benefits
2.2
Career Opportunities
2.2
Source